| Title: |
Reply to the comment on: “Dalbavancin for infective endocarditis: a systematic review of effectiveness, safety, and dosing” |
| Authors: |
Chaldoupis, Anastasios EAff1; Petrakis, VasiliosAff2, Aff3; Ioannou, PetrosAff4; Tsante, Konstantina AAff5; Tsakri, DenyAff6; Domouchtsidou, AglaiaAff7; Baliou, StellaAff8; Vlachaki, MariannaAff6; Mpakosi, AlexandraAff9, Aff10; Fortis, Sotirios PAff11; Samonis, GeorgeAff4, Aff12; Sokou, RozetaAff13; Bonovas, StefanosAff14, Aff15; Siasos, GerasimosAff1; Tsantes, Andreas GAff7, Aff16, IDs1009602605597z_cor1 |
| Source: |
European Journal of Clinical Microbiology & Infectious Diseases. :1-2 |
| Database: |
Springer Nature Journals |